Cancer Cause and Prevention Research in Michigan
Cancer Cause and Prevention Research (93.393) awarded $89.5 million to recipients in Michigan in 65 grants from fiscal 2021 to 2025, 2.5% of the program's national total. Regents of the University of Michigan received the most, $55.9 million.
- Awarded in Michigan$89.5 million
- Awards65
- Share of the program2.5%
- Rank among states12th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 25 | $15.0 million |
| FY 2022 | 24 | $12.4 million |
| FY 2023 | 37 | $17.6 million |
| FY 2024 | 43 | $22.0 million |
| FY 2025 | 40 | $22.5 million |
Recipients in Michigan
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Colleges and universities | 43 | $55.9 million |
| Wayne State University | Colleges and universities | 5 | $12.7 million |
| Van Andel Research Institute | Colleges and universities | 9 | $11.9 million |
| Michigan State University | Nonprofits | 3 | $5.5 million |
| Michigan State University | Colleges and universities | 3 | $1.5 million |
| Inheret, Inc | Small businesses | 1 | $996,027 |
| Henry Ford Health System | Nonprofits | 1 | $967,267 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Michigan?
$89.5 million from fiscal 2021 to 2025, across 65 awards. Michigan ranks 12th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Michigan?
The largest recipient is Regents of the University of Michigan, with $55.9 million in 43 awards. Next are Wayne State University and Van Andel Research Institute.
Can organizations in Michigan apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Michigan
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Temporary Assistance for Needy Families
- National School Lunch Program
- Commercial Technologies for Maintenance Activities Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Child Care and Development Block Grant
- Head Start